Neoadjuvant Therapy Neoadjuvant pembrolizumab can be considered for patients with high-risk node-positive disease or resectable metastatic disease based on the results of a phase II trial (SWOG S1801 [NCT03698019])
Cost Comparison Framework: Formulations and Monthly Investment Evaluating affordability requires comparing not just price, but formulation type, dosing flexibility, and clinical needs
Anti-Aging Powerhouse Targets signs of aging by improving skin elasticity, texture, and tone, while enhancing overall skin radiance
Because orders are processed through a compounding pharmacy, changes must be made before your next order is created
My primary care physician submitted medical documentation explaining that this medication was medically beneficial in my case, yet the requests were still rejected
10.1161/HYPERTENSIONAHA.113.01324 Hypertension 62 HuangZ.HuangL.WangC.ZhuS.QiX.ChenY.et al (2020)